Crescendo Biologics
Crescendo Biologics is a private, clinical stage immuno-oncology company developing targeted T cell enhancing Humabody® therapeutics. Their lead programme, CB307, is a PSMA x CD137 (4-1BB) bispecific molecule aimed at treating various cancers.
- Humabody® therapeutics
- T cell enhancing therapies
- Bispecific molecules for cancer treatment